AC Immune SA (ACIU)
2.82
+0.05
(+1.81%)
USD |
NASDAQ |
May 19, 16:00
2.815
0.00 (0.00%)
After-Hours: 20:00
AC Immune Enterprise Value : 199.27M for May 19, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Kuros Biosciences Ltd. | 966.82M |
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| BeOne Medicines Ltd. | 28.04B |
| CRISPR Therapeutics AG | 2.935B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.89M |
| Revenue (Quarterly) | 1.428M |
| Total Expenses (Quarterly) | 20.31M |
| EPS Diluted (Quarterly) | -0.1914 |
| Profit Margin (Quarterly) | -1.32K% |
| Earnings Yield | -29.09% |